Product image of Granisetron Fresenius Kabi (Granisetron Hydrochloride) supplied by GNH India

Granisetron Fresenius Kabi

Active Ingredient:
Granisetron Hydrochloride
Origin:
EU

Granisetron Fresenius Kabi (Granisetron Hydrochloride)

Granisetron Fresenius Kabi is an injectable medication that contains the active ingredient granisetron hydrochloride. It is supplied as a sterile intravenous solution and is classified as a 5‑HT3 receptor antagonist. The drug is marketed in the European Union and is prescribed by healthcare professionals for the prevention of nausea and vomiting associated with certain medical procedures. It is administered under medical supervision and is available only by prescription.

Manufacturer / TM Owner

Fresenius Kabi Nv/Sa

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Granisetron Fresenius Kabi is indicated for the prevention of nausea and vomiting in several clinical settings, particularly where serotonin-mediated emesis is expected.

  • Prevention of chemotherapy‑induced nausea and vomiting (CINV).
  • Prevention of postoperative nausea and vomiting (PONV).
  • Prevention of nausea and vomiting associated with radiotherapy.
  • Use as part of a prophylactic antiemetic regimen in patients receiving highly emetogenic treatments.
  • Adjunct therapy for nausea related to diagnostic procedures that involve anesthesia.
  • Management of breakthrough nausea when standard antiemetic therapy is insufficient.

Side Effects

The safety profile of Granisetron Fresenius Kabi includes both common and less frequent adverse reactions that have been reported in clinical trials and post‑marketing experience.

Common

  • Headache.
  • Constipation.
  • Dizziness.
  • Fatigue.
  • Diarrhea.
  • Injection site pain.
  • Dry mouth.

Serious

  • Anaphylaxis or severe allergic reaction.
  • Cardiac arrhythmia.
  • QT interval prolongation.
  • Severe hypotension.
  • Serotonin syndrome.
  • Muscle spasms.

Precautions & Warnings

Before initiating therapy with Granisetron Fresenius Kabi, clinicians should evaluate several precautionary factors to ensure safe use.

  • Assess patient history for hypersensitivity to granisetron or other 5‑HT3 antagonists.
  • Use caution in patients with known cardiac conduction disorders or prolonged QT interval.
  • Monitor electrolytes, especially potassium and magnesium, which can affect cardiac rhythm.
  • Consider dose adjustment in patients with hepatic impairment.
  • Evaluate potential risks in pregnant or breastfeeding women, as safety data are limited.

Avoid Interactions

Granisetron Fresenius Kabi may interact with other medications, influencing its efficacy or safety profile.

Avoid

  • Concomitant use with other 5‑HT3 antagonists (e.g., ondansetron) due to additive effects.
  • Co‑administration with drugs known to prolong QT interval (e.g., certain antiarrhythmics, antipsychotics).
  • Use with potent CYP3A4 inducers that may reduce granisetron levels (e.g., rifampin).

Use with caution

  • Combination with serotonergic agents (e.g., SSRIs, tramadol) may increase risk of serotonin syndrome.
  • Concurrent use with other antiemetics that have overlapping mechanisms.
  • Administration with drugs causing significant electrolyte disturbances.

Frequently Asked Questions

Granisetron Fresenius Kabi is an intravenous formulation of granisetron hydrochloride that acts as a selective 5‑HT3 receptor antagonist, blocking serotonin signals that trigger nausea and vomiting.

The product is given by a healthcare professional as an intravenous infusion or injection, typically shortly before the emetogenic stimulus such as chemotherapy or surgery.

It is prescribed for patients undergoing chemotherapy, surgery, or radiotherapy who are at risk of developing nausea and vomiting, as well as for those needing prophylaxis against postoperative emesis.

Common adverse effects include headache, constipation, dizziness, fatigue, diarrhea, injection‑site pain, and dry mouth.

Serious cardiac reactions such as QT interval prolongation, arrhythmias, and severe hypotension have been reported, especially in patients with pre‑existing cardiac conditions or electrolyte imbalances.

The pregnancy safety category is listed as unknown; therefore, it should be used only if the potential benefit justifies the potential risk to the fetus and after consulting a physician.

The solution should be stored in a controlled room temperature environment, protected from light, and kept in its original packaging until administered.

Inform your doctor about any allergies, especially to granisetron or other 5‑HT3 antagonists, existing heart rhythm disorders, liver disease, and all medications you are currently taking.

Yes. Avoid using it together with other 5‑HT3 antagonists or drugs that prolong the QT interval. Use caution with serotonergic agents, CYP3A4 inducers, and medications that affect electrolyte balance.

Both are 5‑HT3 antagonists, but they differ in pharmacokinetic profiles, dosing regimens, and specific approved indications; selection depends on clinical judgment and patient factors.

Patients may be monitored for signs of allergic reaction, cardiac rhythm changes (especially QT interval), and electrolyte levels, particularly if they have risk factors for cardiac events.

Yes, it is approved for the prevention of nausea and vomiting associated with radiotherapy, either alone or as part of a combination antiemetic regimen.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Granisetron Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT